newratings.com  Nov 17  Comment 
LONDON (dpa-AFX) - Medidata Solutions Inc. (MDSO), a provider of cloud-based solutions for clinical research in life sciences, Monday announced the completion of a method development project conducted in partnership with GlaxoSmithKline Plc (GSK,...
Motley Fool  Nov 10  Comment 
Some socially responsible companies can make you wealthy.
Forbes  Nov 6  Comment 
Steve Smith is Director of Patient Value at Medidata Solutions. Outside of this role, he devotes time to patient advocacy, a cause he joined when his son was diagnosed with a rare disease in 1990.
Benzinga  Nov 5  Comment 
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology for clinical research in life sciences, today announced that Mundipharma Research Limited (Mundipharma) has adopted Medidata's cloud-based software platform to...
TheStreet.com  Oct 28  Comment 
NEW YORK (TheStreet) -- Shares of Medidata Solutions were falling 7.1% to $40 Tuesday after missing analysts' estimates for revenue and lowering its full year guidance. The healthcare information services company reported earnings of 20 cents a...
newratings.com  Oct 28  Comment 
WASHINGTON (dpa-AFX) - Medidata Solutions, Inc. (MDSO) Tuesday reported a sharp plunge in net profit for the third quarter of 2014, and revised its full-year 2014 guidance. For the quarter, GAAP net income plummeted to $0.16 million, or $0.00 per...
Benzinga  Oct 14  Comment 
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the latest release of the Medidata Clinical Cloud™ and the immediate availability of new capabilities and...
Forbes  Sep 24  Comment 
Glenn Watt is the vice president of information security and privacy at Medidata Solutions. In this video, he discusses the evolution of cloud security and how security intelligence will play a transformative role in the use of electronic...

Medidata Solutions (NASDAQ:MDSO) sells a software platform called Medidata Rave that helps biotech and pharmaceutical companies enhance the efficiency of their clinical development processes.[1] It achieves this by integrating electronic data capture (EDC) with a clinical data management system (CDMS) in a single product.
Error creating thumbnail
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
The company also sells a protocol authoring tool (Medidata Designer), a grant management system (Medidata Grant Manager) and a CRO contracting platform (Medidata CRO Contractor). In 2007, 2008 and the first quarter of 2009, the company's top five customers by revenue were Johnson & Johnson, AstraZeneca, Amgen, Astellas Pharma and Takeda Pharmaceutical.[1]

Medidata's initial public offering (IPO) of stock is scheduled for 18 June 2009. It plans to sell 6.3 million shares at between $11 and $12 per share. In 2008, the company had $106 million in total revenues, up 67.9% from $63.0 million in 2007. However, it still made a net loss of $18.3 million, down 22.8% from the $23.7 million net loss made in 2007.[2] In the same year, 69% of revenues came from customers in the United States, 21% from Europe and 10% from Asia (including Australia). In the first quarter of 2009, the company had $33.6 million in total revenues, up 60.2% from $21.0 million in the same quarter of the 2008.[2] It also had $1.7 million in net income, up 120% from the $8.6 million net loss made in 2007. Existing investors in the company include Insight Venture Partners (33.9%), chief executive officer and chairman Tarek Sherif (9.0%), president and director Glen M. de Vries (9.0%) and Milestone Venture Partners (7.6%).


  1. 1.0 1.1 Business, 2009 MDSO S-1/A
  2. 2.0 2.1 Selected Consolidated Financial Information, 2009 MDSO S-1/A
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki